Clinical Study
Dose-Escalated Hypofractionated Intensity-Modulated Radiotherapy in High-Risk Carcinoma of the Prostate: Outcome and Late Toxicity
Table 1
Baseline patient characteristics.
| Disease characteristic | Number of Patients (%) |
| Stage | | T1 | 0 (0) | T2 | 19 (32) | T3 | 41 (68) |
| Gleason score | | 2-6 | 18 (30) | 7 | 27 (45) | 8–10 | 15 (25) |
| Presenting PSA (μg/L) | | <10 | 12 (20) | 10–20 | 14 (23) | >20 | 34 (57) |
|
|